Experience without using venoveno bypass in adult orthotopic liver transplantation by Kim, Dae-Young et al.
Korean J Anesthesiol 2011 January 60(1): 19-24 
DOI: 10.4097/kjae.2011.60.1.19  Clinical Research Article
Copyright ⓒ the Korean Society of Anesthesiologists, 2011 www.ekja.org
Background: Venoveno bypass (VVB) has been used to achieve hemodynamic stability and decrease the incidence 
of renal dysfunction. However, VVB has many complications. The purpose of this study is to verify the safety of total 
clamping of the suprahepatic inferior vena cava (IVC) without VVB during orthotropic liver transplantation (OLT) in 
terms of anesthetic management.
Methods: Twenty-five patients without preoperative renal dysfunction who underwent primary OLT were enrolled 
in this study. Hemodynamic data and blood gas measurements were collected 1 hour after incision, 30 minutes after 
IVC total clamping and 30 minutes after reperfusion. Postoperative laboratory data, including blood urea nitrogen 
(BUN), creatinine (Cr) and glomerular filtration rate (GFR), were assessed at postoperative day (POD) 0-7, 30, 90, 
180 and 1 year. 
Results: Mean blood pressure was well maintained during IVC total clamping with infusion of inotropics. There was 
no case of severe acidosis (pH < 7.2) during the anhepatic period. The immediate postoperative Cr and GFR were not 
significantly different from those of the preoperative values. BUN increased from POD 1 and decreased after POD 6, 
while Cr increased at POD 90 only. 
Conclusions: In patients without preoperative renal dysfunction, when IVC was totally clamped, VVB does not need 
to be routinely performed to maintain hemodynamics during the anhepatic phase and renal function after OLT. 
(Korean J Anesthesiol 2011; 60: 19-24)
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Introduction
    Orthotopic liver transplantation (OLT) is considered the 
definitive treatment for end-stage liver disease. The standard 
technique of OLT causes changes in hemodynamics during 
the anhepatic phase because of cross clamping of the 
suprahepatic inferior vena cava (IVC) above the renal vein 
[1,2]. Consequently, interruption of IVC and portal vein flow 
causes a decrease in cardiac output and arterial blood pressure. 
This leads to hypoperfused critical organs, and increased 
systemic vascular resistance. This period is a challenge to 
anesthesiologists to maintain major organ perfusion. 
    Venoveno bypass (VVB) has been used to achieve 
hemodynamic stability and avoid venous congestion, even 
though controversy still persists over some of its benefits [3,4]. 
Piggyback technique has been proposed as an alternative 
procedure [5]. This technique allows IVC venous return to the 
heart, achieving better hemodynamics in the recipient, with 
decreased renal dysfunction. However, the piggyback technique 
has been considered in favorable anatomical conditions, and 
then cross clamping of suprahepatic IVC with or without VVB 
has been performed in almost cases [5,6]. When OLT was 
performed using total IVC clamp without VVB, hemodynamic 
instability during the anhepatic phase recovered promptly after 
reperfusion and renal function was stable after OLT [7]. 
    Over 30% of patients awaiting OLT have decreased renal 
function, and preservation of renal function is closely related to 
mortality and morbidity after OLT [8]. Intraoperative problems, 
such as hypotension, massive transfusion, pre-existing renal 
dysfunction, and reduction of GFR during clamping of IVC and 
portal vein, are major deterioration factors for renal function 
after OLT [9,10]. 
    The aim of this study was to verify whether suprahepatic IVC 
total clamp without VVB during OLT had any effect on renal 
function and hemodynamics. 
Materials and Methods
    Thirty adult patients underwent primary OLT between 
January 2006 and June 2009. We excluded five patients because 
of preoperative renal dysfunction (preoperative creatinine >1.5 
mg/dl) and poor records. 
    All patients were anesthestized in the same manner. 
General anesthesia was maintained using sevoflurane (0.5-
1.5 vol%) and 50% O2-air mixture. Analgesia was provided 
with continuous infusion of remifentanil (0.02-0.1 μg/kg/
min) and muscle relaxation was introduced by vecuronium. 
We monitored five lead electrocardiogram, invasive arterial 
pressure in the radial and femoral artery, central venous 
pressure, pulmonary artery pressure and femoral vein pressure. 
We monitored continuous cardiac output via Vigilance (Baxter 
Healthcare Corp., Irvine, CA, USA). Bispectral index (VISTA
TM, 
Aspect Medical System, USA) and cerebral oximetry (INVOS 
Oximeter, Somanetics, USA) were also monitored. Patients 
were transfused using a rapid infusion device with irradiated 
red blood cells and fresh frozen plasma. Laboratory testing and 
arterial blood gas analysis were performed at each phase, and 
abnormal laboratory finding were corrected, such as acidosis, 
hypocalcemia, and coagulation profiles. Volume replacement 
and inotropics were routinely supported. All patients had 
tranexamic acid administration after reperfusion for 3 hours. 
All patients received standardized immunosuppressions and 
antibiotics prophylaxis following routine procedures in our 
facility.
    All transplantations were performed by a single experienced 
liver transplant surgeon and the operation was performed in a 
similar manner. Suprahepatic IVC was temporarily clamped to 
test patient tolerance to the total interruption of caval flow. If 
the patient did not tolerate the suprahepatic IVC interruption, 
the clamp was released and measured, including infusion 
of volume and inotropics until mean blood pressure (MBP) 
was over 60 mmHg at the femoral artery. As soon as the 
patient tolerated the suprahepatic IVC clamping, the recipient 
hepatectomy was executed without VVB. If MBP was not over 
60 mmHg the VVB would be placed. There was no case to place 
VVB, and the hemodynamics were well maintained in all cases. 
The graft was placed orthotopically and after anastomosing the 
IVC and portal vein, the graft was reperfused.
    Recipient parameters included age, gender, Child Pugh 
score, model of end-stage liver disease (MELD), and creatinine. 
Hemodynamic data including cardiac output, systemic and 
pulmonary vascular resistance, right ventricular end diastolic 
volume index, right and left ventricular stroke work index, and 
pressures was collected at 1 hour after incision, 30 minutes 
after IVC total clamping and 30 minutes after reperfusion. 
Arterial blood gas analysis was performed simultaneously. 
Intraoperative data such as urine output, inotropic support, 
and fluid or blood replacement was obtained. Postoperative 
laboratory results including renal function were assessed 
by creatinine, blood urea nitrogen (BUN), and GFR, at 
postoperative day (POD) 0-7, 30, 90, 180 and 1 year. All 
parameter are expressed as mean ± SDs. Statistical analysis 
was performed using one-way ANOVA and paired t-test. The 
difference was considered significant when the P value was less 
than 0.05.
Results
    OLT with suprahepatic IVC cross clamping without VVB was 
feasible in all cases. Etiology of cirrhosis was viral except one 21 www.ekja.org
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case where cryptogenic liver cirrhosis was observed. Average 
length of operation from skin incision to closure was 850 
minutes (range, 540-1,020 minutes) and the anhepatic phase 
was 112 minutes (range, 65-180 minutes). Child class A, B, and 
C was each 14, 8, and 3 patients (Table 1). Blood transfusion 
and volume replacement is shown in Table 2. All patients were 
infused with inotropics during the anhepatic phase to maintain 
blood pressure. All patients except four were infused with 
diuretics to maintain urine output. Urine output significantly 
decreased during the anhepatic phase and was restored after 
reperfusion. 
    All hemodynamic parameters significantly decreased 
during the anhepatic phase except pulmonary vascular 
resistance, and after reperfusion, restored pre-anhepatic 
value except MBP (Table 3). After test clamping, the extent 
of hemodynamic instability was evaluated, and inotropics 
such as norepinephrine were infused. At the initiation of the 
anhepatic phase, if MBP was below 60 mmHg, phenylnephrine 
was additionally infused (5 patients, median 100 μg, 50-500 
μg). The heart rate increased at the initiation of IVC total clamp, 
but gradually decreased and was stable about 30 minutes after 
IVC clamping. Nine patients experienced post-reperfusion 
Table 3. Hemodynamic Change during Liver Transplantation
Pre-anhepatic Anhepatic Post-anhepatic P value
HR (beats/min)
MBP (mmHg)
CVP (mmHg)
Mean PAP (mmHg)
FVP (mmHg)
CO (L/min)
SVR (dynes∙s/cm
5)
PVR (dynes∙s/cm
5)
EF (%)
SV (ml/beat)
RVEDVI (ml)
LVSWI (g-m/beat/m
2)
RVSWI(g-m/beat/m
2)
SvO2 (%)
BIS
rSO2 left (%)
rSO2 right (%)
75.0 ± 9.7
83.3 ± 8.4
7.5 ± 2.6
18.2 ± 5.3
9.3 ± 3.1
7.4 ± 1.7
953.1 ± 394.8
74.6 ± 34.6
36.7 ± 8.2
96.3 ± 21.3
165.3 ± 42.4
54.0 ± 9.0
8.2 ± 3.7
88.0 ± 3.6
44.9 ± 6.0
66.0 ± 7.2
64.7 ± 8.0
96.7 ± 14.6*
74.5 ± 8.8*
5.6 ± 3.7*
10.1 ± 3.8*
31.0 ± 5.8*
3.9 ± 1.1*
1,552.4 ± 543.6*
91.5 ± 37.5
29.1 ± 9.8*
40.3 ± 15.4*
93.3 ± 35.9*
23.3 ± 12.4*
4.7 ± 7.6*
75.8 ± 9.3*
42.7 ± 8.6
58.7 ± 13.5
58.3 ± 11.5 
82.0 ± 9.9
†
76.0 ± 7.0*
7.8 ± 2.3
†
20.1 ± 3.9
†
10.5 ± 3.1
†
8.7 ± 2.0
†
703.6 ± 238.9
†
75.1 ± 27.0
38.1 ± 7.1
†
102.8 ± 18.1
†
157.0 ± 37.2
†
52.3 ± 7.9
†
7.7 ± 3.4
†
85.6 ± 4.5
†
39.9 ± 8.2
66.4 ± 11.3
65.2 ± 8.8
<0.001
=0.002
=0.042
<0.001
<0.001
<0.001
<0.001
=0.217
=0.004
<0.001
<0.001
<0.001
<0.001
<0.001
0.262
0.047
0.139
All values are mean ± SD. MBP: mean blood pressure, CVP: central venous pressure, PAP: pulmonary artery pressure, FVP: femoral vein pressure, 
CO: cardiac output, SVR: systemic vascular resistance, PVR: pulmonary vascular resistance, EF: ejection fraction, SV: stroke volume, RVEDVI: 
right ventricular end diastolic volume index, LV and RVSWI: left and right ventricular stroke work index, g-m: gram meter, SvO2: mixed venous O2 
saturation, BIS: bispectral index, rSO2: regional cerebral O2 saturation. *P < 0.05 vs pre-anhepatic value, 
†P < 0.05 vs anhepatic value. 
Table 1. Patient Demographic Data
Sex (M/F)
Age (yr)
Height (cm)
Weight (kg)
Child class
MELD score
Underlying disease
A
B
C
Diabetes mellitus
Hypertension
18/7
51.3 ± 4.9
165.6 ± 8.0
66.9 ± 11.1
14
 8
 3 
14.2 ± 6.5
4
2
Values are mean ± SD or numbers. MELD: model of end-stage liver 
disease.
Table 2. Intraoperative Characteristics
Crystalloid (ml)
Colloid (5% albumin, ml)
Packed red cell (U)
Fresh frozen plasma (U)
Platelet concentrate (U)
Cryoprecipitate (U)
Blood loss (ml)
Creatinine (mg/dl)
    Preoperative
    Highest value after OLT
GFR (ml/min)
    Preoperative
    Lowest value after OLT
Urine output (ml/hr)
    Pre-anhepatic phase
    Anhepatic phase 
    Post-anhepatic phase
Diuretics
    Furosemide (mg)
    Mannitol (gm)
Anhepatic inotropic
    Dopamine
    Epinephrine
    Norepinephrine 
    Isobide dinitrate
6,447.1 ± 1,742.8
2,131 ± 790.8
    9.0 ± 9.5 (0-42)
  15.8 ± 8.5 (7-42)
  14.5 ± 6.5 (5-25)
    6.8 ± 3.6 (0-15)
4,783.3 ± 4,191.7
    0.9 ± 0.2
    1.4 ± 0.4*
  85.6 ± 30.0
  58.6 ± 12.5*
123.9 ± 61.8 
  46.0 ± 27.5*
160.4 ± 59.4
  11.6 ± 6.0 (15 patients)
  20.0 ± 3.8 (15 patients)
18
8
12
4
Values are mean ± SD or numbers. OLT: orthotropic liver trans-
plantation, GFR: glomerular filtration rate. *P < 0.05 vs preoperative 
value.22 www.ekja.org
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syndrome and infused epinephrine bolus (median 50 μg; 
range, 30-120 μg). Four patients needed more inotropics after 
reperfusion (norepinephrine 3 patients, epinephrine 1 patient). 
Conversely, six patients stopped inotropics after reperfusion. 
    The arterial blood gas analysis results are shown in Table 4. The 
pH and HCO3
- content significantly decreased at the anhepatic 
phase and after reperfusion, but base excess, K
+, and glucose 
significantly increased. There was no case of severe acidosis 
(pH < 7.2) during the anhepatic phase. Acidosis was treated 
with sodium bicarbonate (median 60 mEq, 20-120 mEq) and 
calcium chloride was infused (median 1,500 mg; range, 600-
4,500 mg) for treatment of hypocalcemia during the anhepatic 
phase. 
    BUN significantly increased at POD 1, 2, 3, 4, 5, and 6 com-
pared to the preoperative value. Creatinine also significantly 
increased at POD 90 compared to preoperative measurements 
(0.89 ± 0.2 mg/dl vs 1.31 ± 0.2 mg/dl, P < 0.05), but creatinine 
did not increase over 2.0 mg/dl except in one patient (Fig. 1). 
Table 4. Arterial Blood Gas Analysis during Liver Transplantation
Pre-anhepatic Anhepatic Post-anhepatic P value
pH
PaCO2 (mmHg)
PaO2 (mmHg)
HCO3
- (mEq/L)
Base excess
Hematocrit
Na
+ (mEq/L)
K
+ (mEq/L)
Ca
2+ (mEq/L)
Glucose (mg/dl)
7.46 ± 0.04
35.4 ± 3.8
273.6 ± 74.7
25.5 ± 3.6
2.0 ± 4.9
32.3 ± 5.4
136.4 ± 4.2
3.5 ± 0.3
1.02 ± 0.08
117.6 ± 32.9
7.34 ± 0.06*
36.6 ± 4.2
259.6 ± 72.4
19.7 ± 1.9*
-5.1 ± 3.5*
30.2 ± 5.2 
135.0 ± 3.6
4.0 ± 0.7*
0.93 ± 0.13*
153.2 ± 39.8*
7.33 ± 0.06*
40.7 ± 4.3*,†
262.7 ± 54.9
21.6 ± 2.6*
-2.6 ± 4.6*
25.8 ± 4.1*,†
135.7 ± 3.6
3.9 ± 0.7*
1.04 ± 0.08
†
215.5 ± 48.1*,†
<0.001
<0.001
0.782
<0.001
<0.001
<0.001
0.174
0.008
0.002
<0.001
All values are mean ± SD. *P < 0.05 vs pre-anhepatic value, 
†P < 0.05 vs anhepatic value. 
Fig. 1. Change of BUN, creatinine and GFR after orthotropic liver 
transplantation. Laboratory data was collected at preoperative, 
immediate postoperative, postoperative 1-7, 30, 90, 180 days 
and 1 year. BUN significantly increased at postoperative 1-6 days 
and creatinine significantly increased at postoperative 90 days. 
GFR did not significantly change. BUN: blood urea nitrogen, GFR: 
glomerular filtration rate. Data presented as mean and SD. *P < 
0.05 vs preoperative value.23 www.ekja.org
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GFR trended to decrease and was lowest at POD 90 but did not 
show statistical difference compared to the preoperative value. 
Other laboratory findings were normalized until POD 90 (data 
not shown). Postoperative mortality occurred in 3 patients until 
3 months, due to primary graft failure in one case and rejection 
in two cases. 
Discussion
    We have performed the suprahepatic IVC total clamping 
method consecutively in 25 OLTs. In this study, suprahepatic 
IVC total clamping without VVB, even though the anhepatic 
phase lasted nearly 2 hours, is a safe method if hemodynamics 
were maintained. During IVC total clamping, inotropics 
including norepinephrine and volume replacement might 
be helpful to maintain MBP. In addition, transient decreased 
renal perfusion pressure does not cause postoperative renal 
dysfunction. 
    The standard technique of OLT is when the retrohepatic vena 
cava is resected with diseased liver [2]. As a consequence the 
venous return to heart is interrupted during the anhepatic 
phase because of clamping of both portal and IVC flow, which 
is associated with a decrease of cardiac output and arterial 
pressure. This leads to reduction of perfusion pressure in critical 
organs including the kidney [1]. This problem was relieved with 
introduction of VVB during OLT. The beneficial effects of VVB 
include improved hemodynamic stability and reduced renal 
congestion during clamping of IVC [1,3,4]. VVB combined with 
OLT restores the normal physiology and maintains a sufficient 
kidney perfusion with lower postoperative dialysis rates [11]. 
VVB has also decreased the early mortality associated with 
problems of intraoperative course [3]. However, VVB may 
be related to complication rates ranging from 10% to 30% 
[3,9]. Complications are caused by accidental decannulation, 
circuit clots, embolic events, prolongation of operation time, 
vessel injury and coagulopathy [3,4]. Massive pulmonary 
thromboembolism resulting in fatal right heart failure and 
congestion of transplant liver has been reported [12]. Accor-
dingly, several studies have been reported that show there is no 
clear advantage for routine use of VVB in OLT, and routine use 
of VVB appears to be hotly debated across many institutions. 
Since Calne and Williams [13] reported a technique to preserve 
the IVC during recipient hepatectomy, surgical techniques 
have been developed. The piggyback technique, which just 
tangentially clamped the recipient’s suprarenal caval segment, 
is becoming widely used for OLT and allows to minimizing 
the hemodynamic disturbances during anhepatic phase and 
induces lower blood product usage, and lower renal failure 
[5,14]. However, the piggyback procedure can also be difficult 
due to intensive inflammatory adhesion between liver and 
IVC [15]. The surgical technique is also dependent of the 
preference of surgeon. Some centers decide on the placement 
of VVB intraoperatively by observing if the patients will 
hemodynamically tolerate the IVC total clamping [16]. Hence, 
we want to report our experience to perform OLT without VVB 
in aspect of anesthetic management and postoperative renal 
function. 
    Our institute uses a conventional technique of OLT 
with  out VVB. Blood pressure and volume index including 
cardiac output significantly decreased with high femoral vein 
pressure during the anhepatic phase, but restored promptly 
after reperfusion except MBP. During the anhepatic phase, 
maintenance of blood pressure was initially supported by 
inotropics including norepinephrine rather than volume 
replacement, and then systemic vascular resistance (SVR) and 
heart rate significantly increased and MBP maintained over 70 
mmHg. If compensatory increase of SVR was insufficient and 
MBP was below 60 mmHg, phenylnephrine was additionally 
infused to maintain the MBP to the target. It is critical that 
lower to normal SVR allows compensatory increase when 
cardiac output is diminished during the anhepatic phase. 
Dopamine was infused for renal protection, and epinephrine 
was also infused for hemodynamic stability. Epinephrine was 
infused in early experience of our institution, but we routinely 
infused norepinephrine these days to maintain hemodynamics 
during anhepatic phase. These drug effects were similar. 
Isobide dinitrate was infused to treat high pulmonary arterial 
pressure and resting pulmonary hypertension in preoperative 
echocardiography. On the other hand, volume replacement 
was limited, because the patient’s volume statues could not be 
accurately evaluated when the IVC was totally clamped. Central 
venous pressure has an accepted range from 0 to 5 mmHg, if 
blood pressure is maintained. However, volume was infused a 
couple of times via rapid infusion system (300 ml/min) at initial 
period of the anhepatic phase. Mild acidosis also developed 
at the anhepatic phase and after reperfusion because of the 
accumulation of acid metabolites and reduction of perfusion, 
and bicarbonate was infused due to base excess. There was 
no patient below pH 7.2. Calcium chloride was also infused 
to correct hypocalcemia induced transfusion and to maintain 
blood pressure at the anhepatic phase. As expected, after IVC 
declamping, femoral vein pressure decreased abruptly and 
MBP returned to the pre-anhepatic level. However, MBP still 
decreased at post-anhepatic phase due to a decrease in SVR, 
even though it was not significant. MBP was maintained by use 
of more inotropics and volume replacement. Four patients were 
infused with more inotropics to maintain MBP.
    Urine output was 46 ml/hr (range, 3-77) and diuretics were 
infused before suprahepatic IVC was totally clamped. Urine 
output was also recovered steadily after reperfusion. Wall et al. 24 www.ekja.org
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[7] reported that hemodynamic changes observed during the 
anhepatic phase restored promptly after reperfusion, and renal 
function remained stable in conventional OLT without VVB. In 
a comparison study for OLT with or without VVB, VVB is not 
required to maintain postoperative renal function after OLT 
when preoperative renal function is positive [17]. Postoperative 
renal dysfunction is reported up to 70% and is associated with 
an independent risk factor of postoperative mortality [8,18]. 
OLT produces major physiologic changes intraoperatively, such 
as alteration of hemodynamics, activation of renal sympathetic 
tone, and reduction of renal perfusion [9,10,19]. The prevalence 
of renal failure after OLT is a serious event. One study of 102 
liver transplantations revealed 25% with pre-transplant renal 
dysfunction and 67% post-transplant impairment [18]. In 
cirrhotic patients, serum creatinine frequently failed to elevate 
above normal even when GFR declined to less than 25 ml/
min [20]. Thus creatinine is an insensitive marker of GFR in 
cirrhotic patients. In this study, GFR tended to steadily increase 
immediately post operation, but decreased at POD 90 (non-
significant). GFR decreased 29% (range, -50-8%) compared to 
preoperative levels during the entire study period. Early severe 
renal dysfunction after OLT has been associated with graft 
failure, infection, immunosuppressants including cyclosporine, 
and increased mortality [18]. We considered nutrition, 
medications, and renal vasoconstriction as a reason for delayed 
decrease of GFR. Renal vasoconstriction was induced by 
activation of sympathetic tone and derangement of hormones 
such as prostaglandin and endothelin [21]. 
    Several limitations are presented in this study. The number 
of patients is small and the methods need to be compared 
with other procedures such as piggyback. In addition, the 
study could not assess the record of intensive care treatment 
during the immediate postoperative period, fluid management 
and usage of diuretics might be affected postoperative renal 
function. In addition, characteristics of donor may be affected 
by the outcome. This study suggests that in patients without 
preoperative renal dysfunction, as far as hemodynamics 
is tolerated after IVC total clamp, VVB does not need to be 
routinely applied to maintain hemodynamic stability during 
orthotopic liver transplantation and postoperative renal 
function. 
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